Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

Khyati N. Shah(Pfizer (United States)), Sourav Bandyopadhyay(University of California, San Francisco), Trever G. Bivona(University of California, San Francisco), Julia Rotow(University of California, San Francisco), Collin M. Blakely(City College of San Francisco), Roma Bhatt(University of California, San Francisco), Sophie Dumont(University of California, San Francisco), Jonathan Kuhn(University of California, San Francisco), Golzar Hemmati(University of California, San Francisco), Angel A. Ku(University of California, San Francisco), Henry J. Haringsma(Clovis Oncology (United States)), Victor Olivas(University of California, San Francisco), Julia Rohrberg, Andrei Goga(University of California, San Francisco), Ashley Maynard(ETH Zurich), Frank McCormick(Frederick National Laboratory for Cancer Research), Victoria E. Wang(University of California, San Francisco), Swati Kaushik(University of California, San Francisco), Gregor Krings(Cleveland Clinic), Andrew D. Simmons(Clovis Oncology (United States)), Liliane Robillard(University of California, San Francisco), Thomas C. Harding(Genesys (United States)), Hayley Donnella(University of California, San Francisco), Maria M. Martins(University of California, San Francisco), Jacqueline Galeas(University of California, San Francisco)
Nature Medicine
November 22, 2018
Cited by 292


Related Papers